Welcome, Guest. Please login or register.
April 20, 2024, 05:47:28 am

Login with username, password and session length


Members
  • Total Members: 6307
  • Latest: golfer
Stats
  • Total Posts: 55126
  • Total Topics: 4851
  • Online Today: 85
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 66
Total: 66

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Options For Patients Who Fail Harvoni Treatment  (Read 23320 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Options For Patients Who Fail Harvoni Treatment
« on: May 05, 2015, 12:37:58 pm »
Turns out, people with genotype 1 of hepatitis C virus who have failed Harvoni (ledipasvir/sofosbuvir) treatment have a pretty decent chance of a cure from a second round of the drug lasting 24 weeks.

In a recent retreatment trial, 71% of study members achieved a sustained virologic response 12 weeks after completing a second therapy.

Note: Those who had gotten their first Harvoni treatment for eight weeks had an 80% cure rate, while those who had failed a 12-week regimen had just a 46% cure rate. 68% of those with cirrhosis were cured on a second try.

For more info: http://www.hepmag.com/articles/Harvoni_retreatment_2501_27162.shtml

Offline Cute

  • Member
  • Posts: 34
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #1 on: May 07, 2015, 08:30:16 am »
The results of the two trials of the drugs used in combination - daclatasvir, asunaprevir and beclabuvir - are published online by JAMA.

The trials, one including people with liver disease, the other without, both saw eradication rates of around 90% and more against a measure of aviremia called sustained virologic response (SVR).

These treatment-experienced groups still achieved SVR12 rates of 87% for patients receiving the drug combo alone and 93% for patients with ribavirin added.

Overall, the authors conclude, SVR12 was achieved by 93% of 202 patients with genotype 1 infection and compensated cirrhosis after 12 weeks of treatment with the fixed-dose combination of daclatasvir, asunaprevir, and beclabuvir, with or without Ribavirin.

"These two studies add to the armamentarium of all-oral interferon-free regimens that have revolutionized management of hepatitis C, not only for patients who are treatment-naïve with no significant liver disease but also for those who are treatment-experienced and those with cirrhosis."

http://www.medicalnewstoday.com/articles/293440.php

Offline pappy

  • Member
  • Posts: 22
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #2 on: May 09, 2015, 03:05:23 pm »
Sounds nice but my doctor does not want to redo Harvoni possibly because of cost but also because of possibility the virus has already developed immunity to drug .


Turns out, people with genotype 1 of hepatitis C virus who have failed Harvoni (ledipasvir/sofosbuvir) treatment have a pretty decent chance of a cure from a second round of the drug lasting 24 weeks.

In a recent retreatment trial, 71% of study members achieved a sustained virologic response 12 weeks after completing a second therapy.

Note: Those who had gotten their first Harvoni treatment for eight weeks had an 80% cure rate, while those who had failed a 12-week regimen had just a 46% cure rate. 68% of those with cirrhosis were cured on a second try.

For more info: http://www.hepmag.com/articles/Harvoni_retreatment_2501_27162.shtml

Offline KW2023

  • Member
  • Posts: 3
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #3 on: October 07, 2015, 05:11:31 pm »
I officially failed Harvoni 12 weeks... I was told "Well you are the first that we have seen, we knew it would happen sooner or later" 

I am devastated.. I was treatment naive.  They will look into resistance testing.
 
« Last Edit: October 07, 2015, 05:19:19 pm by KW2023 »
Started Harvoni-6-24-2015
 GT1a Compensated Cirrhosis
 

  RNA COPIES/ML    RNA IU/ML 
Wk 4    805          298            
Wk 8    105           39          
Wk 10  <40          <15           
Wk 12 < 40              <15       
All Liver enzymes normal at EOT

Offline pappy

  • Member
  • Posts: 22
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #4 on: October 08, 2015, 01:35:36 am »
Sorry to hear about that guess you will be doing a viekira pak with riba next . I am heading into my last month of a six month long script . Its not as easy as harvoni and the effects are much more than harvoni as well good luck .

Offline Scoutdoy

  • Member
  • Posts: 452
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #5 on: October 08, 2015, 01:58:01 am »
KW, sorry to hear that you relapsed, or did you ever go undetected? Hopefully with new technology you can get a new treatment. Hopefully you don't test positive for the resistance. Is it possible for it to still clear even though you tested detected at the 12 week mark. I swear I read of a similar situation on the Harvoni relapse thread of a couple of people who tested positive at 12 weeks but then when undetected. I am gonna look for that thread


Scout
F/49yrs
Genotype 1a
infected 1987-tatoo/military?
Diagnosed 2007
Biopsy F-0
vl 13,900,000
AST 23
ALT 19
Harvoni Treatment 7/27/2015
4 week lab --<12 negative...AST 23 ALT 15
6 week lab -- Undetected.....AST 17 ALT 10
8 week lab---undetected.......AST15 Alt 10
12 week lab---UNDETECTED....AST 15 ALT 9
12 week EOT--1/13/2016----UNDETECTED!
24 week EOT ----UNDETECTED  --AST 18 ALT 12
I AM FREE!

Offline Scoutdoy

  • Member
  • Posts: 452
F/49yrs
Genotype 1a
infected 1987-tatoo/military?
Diagnosed 2007
Biopsy F-0
vl 13,900,000
AST 23
ALT 19
Harvoni Treatment 7/27/2015
4 week lab --<12 negative...AST 23 ALT 15
6 week lab -- Undetected.....AST 17 ALT 10
8 week lab---undetected.......AST15 Alt 10
12 week lab---UNDETECTED....AST 15 ALT 9
12 week EOT--1/13/2016----UNDETECTED!
24 week EOT ----UNDETECTED  --AST 18 ALT 12
I AM FREE!

Offline Scoutdoy

  • Member
  • Posts: 452
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #7 on: October 08, 2015, 02:41:10 am »
KW I found the thread of people who were detected at end of treatment and even some detected past end of treatment who then became undetected....it's remarkable and I think you should read them

http://forums.hepmag.com/index.php?topic=2383.0


Scout
F/49yrs
Genotype 1a
infected 1987-tatoo/military?
Diagnosed 2007
Biopsy F-0
vl 13,900,000
AST 23
ALT 19
Harvoni Treatment 7/27/2015
4 week lab --<12 negative...AST 23 ALT 15
6 week lab -- Undetected.....AST 17 ALT 10
8 week lab---undetected.......AST15 Alt 10
12 week lab---UNDETECTED....AST 15 ALT 9
12 week EOT--1/13/2016----UNDETECTED!
24 week EOT ----UNDETECTED  --AST 18 ALT 12
I AM FREE!

Offline dragonslayer

  • Member
  • Posts: 873
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #8 on: October 08, 2015, 09:44:55 am »
I officially failed Harvoni 12 weeks... I was told "Well you are the first that we have seen, we knew it would happen sooner or later" 

I am devastated.. I was treatment naive.  They will look into resistance testing.

I'm one of those who was detected at EOT and even at 7 wks post treatment, but went on to clear by 12 wks post treatment.  Please list all your viral load tests and their results, ie, when you had them relative to treatment period, and their results.  It will help us interpret  whats going on.

Thanks.
« Last Edit: October 09, 2015, 10:52:14 pm by dragonslayer »
Paul

DX 2008
Started Harvoni 11/26/14 for 8 wks
Completed 8 wks Harvoni 01/20/15
EOT RNA Quant result:  Detected 29
7.5 wk post tx: Detected < LLOQ(12)
11 wk post tx: UNDETECTED SVR12
24 wk post tx: UNDETECTED SVR24; AST 26; ALT 22; ALP 73
48 wk post tx: UNDETECTED SVR48; AST 18; ALT 18; ALP 70
GT 1a
vl 2.4mil
2008 bpx: Stage&Grade 0
2013 bpx: Stage&Grade: 0-1
IL28B: TT
likely infected early '70s

Offline Lynn K

  • Global Moderator
  • Member
  • Posts: 4,544
  • Get tested, get treated, get cured, fight Hep c!
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #9 on: October 08, 2015, 07:25:01 pm »
Hi Pappy

Treatment with viekira pak is not recommended for Harvoni failures due to cross resistance issues

Per the current AASLD guidelines for patients who have failed a treatment with any HCV nonstructural protein 5A (NS5A) inhibitors like ledipasvir/sofosbuvir (Harvoni) amoung others the recommendation is as follows for GT 1:

Recommended regimen for patients in whom previous treatment with any HCV nonstructural protein 5A (NS5A) inhibitors has failed (including daclatasvir plus sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir plus dasabuvir).

For patients with minimal liver disease, deferral of treatment is recommended, pending availability of data.

Rating: Class IIb, Level C

 

For patients with cirrhosis or other patients who require retreatment urgently, testing for resistance-associated variants that confer decreased susceptibility to NS3 protease inhibitors and to NS5A inhibitors is recommended. The specific drugs used in the retreatment regimen should be tailored to the results of this testing as described below. Treatment duration of 24 weeks is recommended and, unless contraindicated, weight-based RBV should be added.

For patients with cirrhosis or other patients who require retreatment urgently, testing for RAVs that confer decreased susceptibility to NS3 protease inhibitors (eg, Q80K) and to NS5A inhibitors should be performed using commercially available assays prior to selecting the next HCV treatment regimen. For patients with no NS5A inhibitor RAVs detected, retreatment with ledipasvir/sofosbuvir and RBV for 24 weeks is recommended. For patients who have NS5A inhibitor RAVs detected and who do not have NS3 inhibitor RAVs detected, treatment with simeprevir, sofosbuvir, and RBV for 24 weeks is recommended. For patients who have both NS3 and NS5A inhibitor RAVs detected, retreatment should be conducted in a clinical trial setting, as an appropriate treatment regimen cannot be recommended at this time.

No data are yet available on the retreatment of patients for whom prior treatment with PrOD has failed. However, studies that have evaluated patients whose virus did not respond to PrOD have reported the presence of RAVs that confer decreased susceptibly to NS3 protease inhibitors (eg, paritaprevir), NS5A inhibitors (eg, daclatasvir, ledipasvir, ombitasvir), and nonnucleoside polymerase inhibitors (eg, dasabuvir). Based on these observations, patients for whom treatment with PrOD did not result in an SVR should have HCV treatment deferred in the setting of mild liver disease, and for those with advanced fibrosis, testing for RAVs should be performed.

Data on the retreatment of patients for whom prior treatment with ledipasvir/sofosbuvir has failed are very limited. In a pilot study, 41 patients with and without cirrhosis who did not achieve an SVR with 8 weeks or 12 weeks of ledipasvir/sofosbuvir were retreated with 24 weeks of ledipasvir/sofosbuvir. SVR12 rates varied according to the presence or absence of NS5A inhibitor RAVs. Among 11 patients for whom NS5A inhibitor RAVs were not detected, SVR occurred in 11 of 11 (100%); in contrast, among 30 patients for whom NS5A inhibitor RAVs were detected, SVR occurred in 18 of 30 (60%). Importantly, NS5B inhibitor RAVs (eg, S282T) known to confer decreased activity of sofosbuvir were observed in 3 of 12 (25%) patients for whom the retreatment regimen was not successful. Similarly, in the OPTIMIST-2 study in which patients with cirrhosis were treated with simeprevir and sofosbuvir, the presence of NS3 RAVs, namely the Q80K polymorphism, led to a decreased SVR rate in patients with HCV genotype 1a infection. SVR occurred in 25 of 34 (74%) patients with HCV genotype 1a and the Q80K RAV and in 35 of 38 (92%) patients with HCV genotype 1a without the Q80K RAV. Based on these data, retreatment for patients for whom an NS5A inhibitor-containing regimen has failed should be considered in the context of retreatment urgency and the presence or absence of RAVs to inhibitors of NS3 and NS5A. Further, based on limited data, RBV is recommended as part of all retreatment regimens for patients in whom prior treatment with NS5A inhibitors has failed. Although no data exist, consideration may also be given to the addition of PEG-IFN to the retreatment regimen in patients who are eligible for this agent; PEG-IFN will have antiviral activity regardless of the RAVs present.

http://www.hcvguidelines.org/full-report/retreatment-persons-whom-prior-therapy-has-failed
Genotype 1a
1978 contracted, 1990 Dx
1995 Intron A failed
2001 Interferon Riba null response
2003 Pegintron Riba trial med null response
2008 F4 Cirrhosis Bx
2014 12 week Sov/Oly relapse
10/14 fibroscan 27 PLT 96
2014 24 weeks Harvoni 15 weeks Riba
5/4/15 EOT not detected, ALT 21, AST 20
4 week post not detected, ALT 26, AST 28
12 week post NOT DETECTED (07/27/15)
ALT 29, AST 27 PLT 92
24 week post NOT DETECTED! (10/19/15)
44 weeks (3/11/16)  fibroscan 33, PLT 111, HCV NOT DETECTED!
I AM FREE!

Offline Lynn K

  • Global Moderator
  • Member
  • Posts: 4,544
  • Get tested, get treated, get cured, fight Hep c!
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #10 on: October 08, 2015, 07:31:20 pm »
Hi KW2023

As Dragon slayer said it is possible you could still clear the virus.

You posted you were " Minimally detectable at week 12" was that at EOT or 12 weeks post?

What is minimally detectable? Dragon and several others here were also " Minimally detectable at week 12" and went on to be SVR at a later time.

Don't give up just yet

Lynn
Genotype 1a
1978 contracted, 1990 Dx
1995 Intron A failed
2001 Interferon Riba null response
2003 Pegintron Riba trial med null response
2008 F4 Cirrhosis Bx
2014 12 week Sov/Oly relapse
10/14 fibroscan 27 PLT 96
2014 24 weeks Harvoni 15 weeks Riba
5/4/15 EOT not detected, ALT 21, AST 20
4 week post not detected, ALT 26, AST 28
12 week post NOT DETECTED (07/27/15)
ALT 29, AST 27 PLT 92
24 week post NOT DETECTED! (10/19/15)
44 weeks (3/11/16)  fibroscan 33, PLT 111, HCV NOT DETECTED!
I AM FREE!

Offline KW2023

  • Member
  • Posts: 3
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #11 on: October 09, 2015, 01:57:26 pm »
Sorry to hear about that guess you will be doing a viekira pak with riba next . I am heading into my last month of a six month long script . Its not as easy as harvoni and the effects are much more than harvoni as well good luck .

Thanks Pappy
 I am not a candidate for any therapy that includes  riba as I was on it for 2 weeks and did not tolerate it.  I did not want to stop but since I developed such severe side effects my MD will not let me continue to take it. They added it at week 8 as I was considered a "slow responder" at that time.

Due to the severe side effects I was given an extra 4 weeks of Harvoni.(gift from my insurance per my MD) I posted  that I was a non responder as my MD said that if I was ND at 12 weeks I will not be at 16 weeks. But after reading  some of the graciously posted articles and posts  I have some hope. Thanks for the kind words and hope.
Started Harvoni-6-24-2015
 GT1a Compensated Cirrhosis
 

  RNA COPIES/ML    RNA IU/ML 
Wk 4    805          298            
Wk 8    105           39          
Wk 10  <40          <15           
Wk 12 < 40              <15       
All Liver enzymes normal at EOT

Offline KW2023

  • Member
  • Posts: 3
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #12 on: October 09, 2015, 02:01:44 pm »
KW, sorry to hear that you relapsed, or did you ever go undetected? Hopefully with new technology you can get a new treatment. Hopefully you don't test positive for the resistance. Is it possible for it to still clear even though you tested detected at the 12 week mark. I swear I read of a similar situation on the Harvoni relapse thread of a couple of people who tested positive at 12 weeks but then when undetected. I am gonna look for that thread


Scout

Hi Scout,
 Thanks for the information.. I have some hope now.
Started Harvoni-6-24-2015
 GT1a Compensated Cirrhosis
 

  RNA COPIES/ML    RNA IU/ML 
Wk 4    805          298            
Wk 8    105           39          
Wk 10  <40          <15           
Wk 12 < 40              <15       
All Liver enzymes normal at EOT

Offline GLCII

  • Member
  • Posts: 127
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #13 on: October 09, 2015, 04:16:38 pm »
KW2023

They now have Hep C by the throat. Harvoni is just the first step and a good one in finding a cure. The next round of new drugs is going to be the one to deliver the knockout punch and illiminate it. It think you have alot of hope, of being cure, in the very near future. Most of us here failed multiple treatments prior to harvoni and know exactly how you feel. I think your time is coming very soon.   ;)
Pre Tx (VL 12043488) ALT 52/ AST 39
Harvoni Start Date 03/12
2 Week in Tx Results HCV RNA Detected, less than 15 IU/mL. ALT 19 / AST 19
4 Weeks in Tx Results HCV RNA Not detected. ALT 21 / AST 18
12 Week in Tx Results HCV RNA Not detected. ALT 17 / AST 19
--------------------------------------------------------------
Post 12 Week EOT Tx ALT 19/ AST 19 (Undetected)
Post 24 Week EOT Tx ALT 19/ AST 15 (Undetected)

Offline Scoutdoy

  • Member
  • Posts: 452
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #14 on: October 09, 2015, 07:23:25 pm »
KW....seriously....4 weeks from now I bet you are undetected! You'll see.... Message me when you do



Scout
F/49yrs
Genotype 1a
infected 1987-tatoo/military?
Diagnosed 2007
Biopsy F-0
vl 13,900,000
AST 23
ALT 19
Harvoni Treatment 7/27/2015
4 week lab --<12 negative...AST 23 ALT 15
6 week lab -- Undetected.....AST 17 ALT 10
8 week lab---undetected.......AST15 Alt 10
12 week lab---UNDETECTED....AST 15 ALT 9
12 week EOT--1/13/2016----UNDETECTED!
24 week EOT ----UNDETECTED  --AST 18 ALT 12
I AM FREE!

Offline Lynn K

  • Global Moderator
  • Member
  • Posts: 4,544
  • Get tested, get treated, get cured, fight Hep c!
Re: Options For Patients Who Fail Harvoni Treatment
« Reply #15 on: October 09, 2015, 08:49:26 pm »
yes you situation looks very similar to the other folks who eventually made SVR

Seems like guessing here that the test is picking up maybe dead and dying virus or fragments of virus but anyway not able to reproduce virus.

See if you can get a 4 week post HCV RNA by PCR most relapses occur in th efirst 4 weeks post you will likely see a rise in liver functions and the viral load will jump back to pretreatment levels if there has been a relapse. If not a huge increase in viral load and hopefully not detected at that point you could still make SVR and your doctor will learn about a different scenario of post treatment testing results.

Wishing you only good news
Lynn
Genotype 1a
1978 contracted, 1990 Dx
1995 Intron A failed
2001 Interferon Riba null response
2003 Pegintron Riba trial med null response
2008 F4 Cirrhosis Bx
2014 12 week Sov/Oly relapse
10/14 fibroscan 27 PLT 96
2014 24 weeks Harvoni 15 weeks Riba
5/4/15 EOT not detected, ALT 21, AST 20
4 week post not detected, ALT 26, AST 28
12 week post NOT DETECTED (07/27/15)
ALT 29, AST 27 PLT 92
24 week post NOT DETECTED! (10/19/15)
44 weeks (3/11/16)  fibroscan 33, PLT 111, HCV NOT DETECTED!
I AM FREE!

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.